Abcuro, Inc. is a biotechnology company headquartered in Newton, Massachusetts, focused on developing advanced immunotherapies to treat autoimmune diseases and cancer.
Subscribe to see Abcuro, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Abcuro, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $39.4M in August 2026. Xcout tracks 28 named people at Abcuro, Inc., including Alex Martin (Chief Executive Officer).
22 more named people on record for Abcuro, Inc., with roles, board committees and tenure — see the full roster →
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $39.4M | — | |
| Series C | $200M | 13 named | |
| SEC Form D filing | $120.1M | — | |
| — | $42M | 13 named | |
| SEC Form D filing | $15.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Abcuro, Inc.'s closest competitors — see the full list of competitors and alternatives →
Auron Therapeutics, Inc. is a biotechnology company headquartered in Newton, Massachusetts. The company focuses on targeting cell states to deliver next-generation targeted cancer therapies.
Accropeutics (Accro Bioscience) is a biotechnology research company headquartered in Suzhou, Jiangsu, China. The company discovers and develops innovative drugs targeting inflammation, autoimmune diseases, and cancer.
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Apogee Therapeutics is a biotechnology company focused on the development of therapies for inflammatory and immunology diseases. The company is headquartered in Waltham, Massachusetts.
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, with an additional office in Belgium. The company focuses on discovering and developing novel immuno-oncology therapeutics for cancer treatment.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.